NeuroMetrix Statistics
Total Valuation
NeuroMetrix has a market cap or net worth of $7.24 million. The enterprise value is -$10.15 million.
| Market Cap | 7.24M |
| Enterprise Value | -10.15M |
Important Dates
The next estimated earnings date is Thursday, July 25, 2024, before market open.
| Earnings Date | Jul 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NeuroMetrix has 2.01 million shares outstanding. The number of shares has increased by 88.57% in one year.
| Shares Outstanding | 2.01M |
| Shares Change (YoY) | +88.57% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.12% |
| Owned by Institutions (%) | 2.42% |
| Float | 1.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.91, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.91 |
| Quick Ratio | 9.78 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.80% and return on invested capital (ROIC) is -45.85%.
| Return on Equity (ROE) | -39.80% |
| Return on Assets (ROA) | -37.10% |
| Return on Capital (ROIC) | -45.85% |
| Revenue Per Employee | $202,700 |
| Profits Per Employee | -$307,111 |
| Employee Count | 26 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.93% in the last 52 weeks. The beta is 2.16, so NeuroMetrix's price volatility has been higher than the market average.
| Beta (5Y) | 2.16 |
| 52-Week Price Change | -53.93% |
| 50-Day Moving Average | 4.03 |
| 200-Day Moving Average | 3.97 |
| Relative Strength Index (RSI) | 38.00 |
| Average Volume (20 Days) | 7,226 |
Short Selling Information
The latest short interest is 17,486, so 0.87% of the outstanding shares have been sold short.
| Short Interest | 17,486 |
| Short Previous Month | 16,858 |
| Short % of Shares Out | 0.87% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 1.77 |
Income Statement
In the last 12 months, NeuroMetrix had revenue of $5.27 million and -$7.98 million in losses. Loss per share was -$6.26.
| Revenue | 5.27M |
| Gross Profit | 3.27M |
| Operating Income | -8.70M |
| Pretax Income | -7.98M |
| Net Income | -7.98M |
| EBITDA | -7.91M |
| EBIT | -7.98M |
| Loss Per Share | -$6.26 |
Balance Sheet
The company has $17.60 million in cash and $209,337 in debt, giving a net cash position of $17.39 million or $8.65 per share.
| Cash & Cash Equivalents | 17.60M |
| Total Debt | 209,337 |
| Net Cash | 17.39M |
| Net Cash Per Share | $8.65 |
| Equity (Book Value) | 18.76M |
| Book Value Per Share | 9.32 |
| Working Capital | 18.30M |
Cash Flow
In the last 12 months, operating cash flow was -$7.04 million and capital expenditures -$183,542, giving a free cash flow of -$7.23 million.
| Operating Cash Flow | -7.04M |
| Capital Expenditures | -183,542 |
| Free Cash Flow | -7.23M |
| FCF Per Share | -$3.99 |
Margins
Gross margin is 61.97%, with operating and profit margins of -164.99% and -151.51%.
| Gross Margin | 61.97% |
| Operating Margin | -164.99% |
| Pretax Margin | -151.51% |
| Profit Margin | -151.51% |
| EBITDA Margin | -150.17% |
| EBIT Margin | -151.51% |
| FCF Margin | -137.16% |
Dividends & Yields
NeuroMetrix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -88.57% |
| Shareholder Yield | -88.57% |
| Earnings Yield | -110.26% |
| FCF Yield | -99.82% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 22, 2023. It was a reverse split with a ratio of 1:8.
| Last Split Date | Nov 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
NeuroMetrix has an Altman Z-Score of -12.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.12 |
| Piotroski F-Score | 2 |